191 related articles for article (PubMed ID: 17893513)
21. Norcantharidin induces human melanoma A375-S2 cell apoptosis through mitochondrial and caspase pathways.
An WW; Wang MW; Tashiro S; Onodera S; Ikejima T
J Korean Med Sci; 2004 Aug; 19(4):560-6. PubMed ID: 15308848
[TBL] [Abstract][Full Text] [Related]
22. Norcantharidin blocks Wnt/β-catenin signaling via promoter demethylation of WIF-1 in glioma.
Xie D; Xie J; Wan Y; Ma L; Qi X; Wang K; Yang S
Oncol Rep; 2016 Apr; 35(4):2191-7. PubMed ID: 26781164
[TBL] [Abstract][Full Text] [Related]
23. Norcantharidin induce apoptosis in human nasopharyngeal carcinoma through caspase and mitochondrial pathway.
Chen AW; Tseng YS; Lin CC; Hsi YT; Lo YS; Chuang YC; Lin SH; Yu CY; Hsieh MJ; Chen MK
Environ Toxicol; 2018 Mar; 33(3):343-350. PubMed ID: 29193574
[TBL] [Abstract][Full Text] [Related]
24. [Molecular mechanism of norcantharidin inducing apoptosis in liver cancer cells].
Li GQ; Zhang SJ; Lü JF; Wu Y; Li J; Zhang G; Yu JT
Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(30):2145-8. PubMed ID: 21029633
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and antiproliferative assay of norcantharidin derivatives in cancer cells.
Tu GG; Zhan JF; Lv QL; Wang JQ; Kuang BH; Li SH
Med Chem; 2014 Jun; 10(4):376-81. PubMed ID: 23909288
[TBL] [Abstract][Full Text] [Related]
26. Norcantharidin Inhibits cell growth by suppressing the expression and phosphorylation of both EGFR and c-Met in human colon cancer cells.
Qiu P; Wang S; Liu M; Ma H; Zeng X; Zhang M; Xu L; Cui Y; Xu H; Tang Y; He Y; Zhang L
BMC Cancer; 2017 Jan; 17(1):55. PubMed ID: 28086832
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and anti-cancer activity evaluation of podophyllotoxin-norcantharidin hybrid drugs.
Han HW; Qiu HY; Hu C; Sun WX; Yang RW; Qi JL; Wang XM; Lu GH; Yang YH
Bioorg Med Chem Lett; 2016 Jul; 26(14):3237-3242. PubMed ID: 27262599
[TBL] [Abstract][Full Text] [Related]
28. Anticancer effects of O-desmethylangolensin are mediated through cell cycle arrest at the G2/M phase and mitochondrial-dependent apoptosis in Hep3B human hepatocellular carcinoma cells.
Choi EJ; Lee JI; Kim GH
Int J Mol Med; 2013 Mar; 31(3):726-30. PubMed ID: 23314756
[TBL] [Abstract][Full Text] [Related]
29. Effect of norcantharidin on the human breast cancer Bcap-37 cells.
Liu D; Shi P; Yin X; Chen Z; Zhang X
Connect Tissue Res; 2012; 53(6):508-12. PubMed ID: 22606958
[TBL] [Abstract][Full Text] [Related]
30. Metal-organic framework IRMOFs coated with a temperature-sensitive gel delivering norcantharidin to treat liver cancer.
Li XY; Guan QX; Shang YZ; Wang YH; Lv SW; Yang ZX; Wang R; Feng YF; Li WN; Li YJ
World J Gastroenterol; 2021 Jul; 27(26):4208-4220. PubMed ID: 34326620
[TBL] [Abstract][Full Text] [Related]
31. Primary in vitro and in vivo evaluation of norcantharidin-chitosan/poly (vinyl alcohol) for cancer treatment.
Li M; Xu X; Lu F; Guo S
Drug Deliv; 2014 Jun; 21(4):293-301. PubMed ID: 24156408
[TBL] [Abstract][Full Text] [Related]
32. Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175.
Hayward RL; Schornagel QC; Tente R; Macpherson JS; Aird RE; Guichard S; Habtemariam A; Sadler P; Jodrell DI
Cancer Chemother Pharmacol; 2005 Jun; 55(6):577-83. PubMed ID: 15726367
[TBL] [Abstract][Full Text] [Related]
33. FAM46C is critical for the anti-proliferation and pro-apoptotic effects of norcantharidin in hepatocellular carcinoma cells.
Zhang QY; Yue XQ; Jiang YP; Han T; Xin HL
Sci Rep; 2017 Mar; 7(1):396. PubMed ID: 28341836
[TBL] [Abstract][Full Text] [Related]
34. Regulation of demethylation and re-expression of RASSF1A gene in hepatocellular carcinoma cell lines treated with NCTD in vitro.
Wang Y; Xu M; Di ZH; Zhang J; Mao XQ; Sun HB
J Cancer Res Ther; 2015; 11(4):818-22. PubMed ID: 26881524
[TBL] [Abstract][Full Text] [Related]
35. Treatment for Hepatocellular Carcinoma Is Enhanced When Norcantharidin Is Encapsulated in Exosomes Derived from Bone Marrow Mesenchymal Stem Cells.
Liang L; Zhao L; Wang Y; Wang Y
Mol Pharm; 2021 Mar; 18(3):1003-1013. PubMed ID: 33527831
[TBL] [Abstract][Full Text] [Related]
36. SLXM-2, a derivative of cyclophosphamide: mechanism of growth inhibition on hepatocarcinoma 22 cells.
Pang LP; Huang W; Sun Q; Guo W; Li RT; Cui JR
Anticancer Drugs; 2008 Feb; 19(2):167-74. PubMed ID: 18176113
[TBL] [Abstract][Full Text] [Related]
37. The anti-proliferative effects of norcantharidin on human HepG2 cells in cell culture.
Chang C; Zhu Y; Tang X; Tao W
Mol Biol Rep; 2011 Jan; 38(1):163-9. PubMed ID: 20333548
[TBL] [Abstract][Full Text] [Related]
38. Norcantharidin inhibits pre-replicative complexes assembly of HepG2 cells.
Chen S; Qu X; Wan P; Li QW; Wang Z; Guo F; Bai L; Hu Z; Tan W; Li J
Am J Chin Med; 2013; 41(3):665-82. PubMed ID: 23711148
[TBL] [Abstract][Full Text] [Related]
39. Anticancer activity and mechanisms of diacetyldianhydrogalactitol on hepatoma QGY-7703 cells.
Zhang XY; Lian Yan X; Guo W; Xu B; Li M; Zhou Y; Rong Cui J
Anticancer Drugs; 2009 Nov; 20(10):926-31. PubMed ID: 19741503
[TBL] [Abstract][Full Text] [Related]
40. Physalis angulata induced G2/M phase arrest in human breast cancer cells.
Hsieh WT; Huang KY; Lin HY; Chung JG
Food Chem Toxicol; 2006 Jul; 44(7):974-83. PubMed ID: 16427178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
